.
ResMed Inc (ASX:RMD) has had a healthy first half of profit-making, posting record revenue and income for the first six months of the financial year.
The medical manufacturer announced net income for the six months to December 31 of $US167.6 million, up 12 per cent on the same period a year ago.
Resmed’s board declared a quarterly dividend of 25 US cents per share.
Despite the strong result, ResMed chief executive Mick Farrell says the company is disappointed with its US numbers, which have been hit by competitor activity.
Mr Farrell says the group has identified growth opportunities in sleep, respiratory care and cardiorespiratory markets.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$41.25 |
Change
0.120(0.29%) |
Mkt cap ! $23.89B | |||
| Open | High | Low | Value | Volume |
| $41.47 | $41.47 | $41.23 | $34.47M | 834.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89 | $41.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $41.50 | 1500 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| RMD (ASX) Chart |